{"id":"W4400741621","doi":"10.1080/13696998.2024.2379212","title":"Modelling the opportunity for cost-savings or patient access with biosimilar adalimumab and tocilizumab: a European perspective","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Fresenius Kabi","keywords":"Biosimilar; Medicine; Tocilizumab; Adalimumab; Intensive care medicine; Rheumatoid arthritis; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001785699,0.0001356925,0.0003061437,0.00006991759,0.0001262749,0.0001067428,0.000355425,0.0001608446,0.000310239],"category_scores_gemma":[0.0003773882,0.00006484593,0.0001200249,0.00006098531,0.0003640621,0.0001388786,0.0001214382,0.0005933103,0.000002131112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008994299,"about_ca_system_score_gemma":0.0004612569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002701142,"about_ca_topic_score_gemma":0.00001993803,"domain_scores_codex":[0.9989063,0.0001987611,0.0004434401,0.0001862453,0.00005873913,0.0002065467],"domain_scores_gemma":[0.998696,0.0007484533,0.0001813135,0.0001119261,0.0001292358,0.0001330946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01255923,0.0009578685,0.0001930178,0.0005284844,0.006692414,0.0009138798,0.009607535,0.002662713,0.000385164,0.06441485,0.07388407,0.8272008],"study_design_scores_gemma":[0.005789577,0.005111469,0.00006828432,0.001045833,0.0008820991,0.00471732,0.009522727,0.08102007,0.002022415,0.01151985,0.877641,0.000659413],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.576734,0.0300874,0.1645153,0.2162317,0.003951794,0.001989465,0.000360804,0.0001005452,0.006029012],"genre_scores_gemma":[0.9835742,0.00644325,0.003047939,0.006115079,0.0004137892,0.00001193966,0.000004326625,0.00004846123,0.000341006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8265414,"threshold_uncertainty_score":0.3396899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08273379655443044,"score_gpt":0.3413688276508669,"score_spread":0.2586350310964365,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}